Brickell Biotech Reports Second Quarter 2022 Financial Results and Provides Corporate Update

Provided By Globe Newswire

Last update: Aug 11, 2022

Phase 1 study of BBI-02 progressing well and expect to initiate MAD part of the study next month

On track to report SAD and MAD topline results from BBI-02 Phase 1 study by early 2023